Cargando…
Familial Partial Lipodystrophy—Literature Review and Report of a Novel Variant in PPARG Expanding the Spectrum of Disease-Causing Alterations in FPLD3
Familial partial lipodystrophy (FPLD) is a rare genetic disorder characterized by the selective loss of adipose tissue. Its estimated prevalence is as low as 1 in 1 million. The deficiency of metabolically active adipose tissue is closely linked with a wide range of metabolic complications, such as...
Autores principales: | Rutkowska, Lena, Salachna, Dominik, Lewandowski, Krzysztof, Lewiński, Andrzej, Gach, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139680/ https://www.ncbi.nlm.nih.gov/pubmed/35626278 http://dx.doi.org/10.3390/diagnostics12051122 |
Ejemplares similares
-
Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias, Christos, et al.
Publicado: (2020) -
Rapid response to leptin therapy in a FPLD patient with a novel PPARG missense variant
por: Melzer, Fiona, et al.
Publicado: (2021) -
Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
por: Vasandani, Chandna, et al.
Publicado: (2022) -
Polycystic ovary syndrome in familial partial lipodystrophy type 2 (FPLD2): basic and clinical aspects
por: Gambineri, Alessandra, et al.
Publicado: (2018) -
MON-695 Multiple Recurrent Lipomatoses with Thiazolidinedione Therapy in Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Patni, Nivedita, et al.
Publicado: (2020)